Full Length Research Paper
References
Alarcon-Aguilar FJ, Roman-Ramos R, Flores-Saenz JL, Aguirre-Garcia F (2002). Investigation on the hypoglycaemic effects of extracts of four Mexican medicial plants in normal and alloxan-diabeti mice. Phyto. Res. 16(4):383-386. Crossref |
||||
Ali-Shtayeh MS, Jamous RM, Jamous RM (2012). Complementary and alternative medicine use amongst Palestinian diabetic patients. Complement. Ther. Clin. Pract. 18(1):16-21. Crossref |
||||
Allard T, Wenner T, Greten HJ, Efferth T (2013). Mechanisms of herb-induced nephrotoxicity. Curr. Med. Chem. 20:2812-9. Crossref |
||||
Al-Rowais NA (2002). Herbal medicine in the treatment of diabetes mellitus. Saudi Med. J. 23:1327-31. Pubmed |
||||
Arlt VM, Stiborova M, Schmeiser HH (2002). Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17:265-277. Crossref |
||||
Awad A, Al-Rabiy S, Abahussain E (2008). Self-medication practices among diabetic patients in Kuwait. Med. Princ. Pract. 17(4):315-20. Crossref |
||||
Baricevic D, Bartol T (2000). The biological/ pharmacological activity of the Salvia genus. In Sage-the Genus Salvia, [SE Kintzios, editor]. Amsterdam: Harwood Academic publishers. pp. 143-184. | ||||
Bellakhdar J, Claisse R, Fleurentin J, Younos C (1991). Repertory of standard herbal drugs in the Moroccan pharmacopoea. J. Ethnopharmacol. 35:123-143. Crossref |
||||
Ceylan S, Azal O, Taslipinar A, Türker T, Açikel CH, Gulec M (2009). Complementary and alternative medicine use among Turkish diabetes patients. Compl. Ther. Med. 17:78-83. Crossref |
||||
Chavez ML, Jordan MA, Chavez PI (2006). Evidence-based drug-herbal interactions. Life Sci. 78:2146-57. Crossref |
||||
Eddouks M, Maghrani M, Lemhadri A, Ouahidi ML, Jouad H (2002). Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Taï¬lalet). J. Ethnopharmacol. 82:97-103. Crossref |
||||
Eidi M, Eidi A, Zamanizadeh H (2005). Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J. Ethnopharmacol. 100:310-313. Crossref |
||||
Emslie M, Campbell M, Walker K (1996). Complementary therapies in a local healthcare setting Part 1. Is there real public demand? Complement Ther. Med. 4:39-42. Crossref |
||||
Food and Drug Administration. Dietary supplements: aristolochic acid. http://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm096388.htm . Accessed on May 28th, 2014. | ||||
Hamza N, Berke B, Cheze C, Le Garrec R, Lassalle R, Agli AN, Robinson P, Gin H, Moore N (2011). Treatment of high fat diet induced type 2 diabetes in C57BL/6J mice by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J. Ethnopharmacol. 133:931-933. Crossref |
||||
Hamza N, Berke B, Cheze C, Agli AN, Robinson P, Gin H, Moore N (2010). Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J. Ethnopharmacol. 128:513-518. Crossref |
||||
Hmamouchi M. Plantes médicinales et aromatiques du Maroc.2nd Edition, 2001. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Volume 82. Lyons, France: IARC Press, 2002.Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. International Diabetes Federation, IDF, Diabetes Atlas. 6th Ed.: International Diabetes Federation; 2012. | ||||
Jouad H, Haloui M, Rhiouani H, El Hilaly J, Eddouks M (2001). Ethnobotanical survey of medicinal plants used for the treatment of diabetes, cardiac and renal diseases in the North centre region of Morocco (Fez–Boulemane). J. Ethnopharmacol. 77:175-182. Crossref |
||||
Kabbaj F, Meddah B, Cherrah Y, Faouzi A (2012). Ethnopharmacological profile of traditional plants used in Morocco by cancer patients as herbal therapeutics. Phytopharmacology. 2:243-256. | ||||
Kaeidi A, Esmaeili-Mahani S, Sheibani V Abbasnejad M, Rasoulian B, Hajializadeh Z, Afrazi S (2011). Olive (Olea europea L.) leaf extract attenuates early diabetic neuropathic patin through prevention of high glucose-induced apoptosis : in vitro and in vivo studies. J. Ethnopharmacol. 136:188-196. Crossref |
||||
Kumar D, Bajaj S, Mehrotra R (2006). Knowledge, attitude and practice of complementary and alternative medicines for diabetes. Public Health.120:705-711. Crossref |
||||
Lemhadri A, Zeqqwagh A, Maghrani M, Jouad H, Eddouks M (2004). Anti-hyperglycaemic activity of the aqueous extract of Origanum vulgare growing winld in Tafilalet region. J. Ethnopharmacol. 92:251-256. Crossref |
||||
Lew-Ting CY (2003). Who uses non-biomedical, complement and alternative health care? Sociodemographic undifferentiation and the effects of health needs. Taiwan J. Public Health. 22:155-66. | ||||
Lima CF, Azevedo MF, Araujo R, Fernandes-Ferreira M, Pereira-Wilson C (2006). Metformin-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention? Br. J. Nutr. 96:326-33. Crossref |
||||
Lim MK, Sadarangani P, Chan HL, Heng JY (2005). Complementary and alternative medicine use in multiracial Singapore. Complementery Ther. Med. 13:16-24. Crossref |
||||
MacLennan AH, Wilson DH, Taylor AW (1996). Prevalence and cost of alternative medicine in Australia. Lancet 347:569-573. Crossref |
||||
McFarland B, Bigelow D, Zani B, Newsom J, Kaplan M (2002). Complementary and alternative medicine use in Canada and the United States. Am. J. Public Health. 92:1616-1618. Crossref |
||||
Moradabadi L, Montasser Kouhsari S, Fehresti Sani M (2013). Hypoglycemic Effects of Three Medicinal Plants in Experimental Diabetes: Inhibition of Rat Intestinal α-glucosidase and Enhanced Pancreatic Insulin and Cardiac Glut-4 mRNAs Expression. Iran J. Pharm. Res.12:387-397. Pubmed |
||||
Otoom SA, Al-Safi SA, Kerem ZK, Alkofahi A (2006). The use of medicinal herbs by diabetic Jordanian patients. J. Herb Pharmacother. 6:31-41. Crossref |
||||
Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005). Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 13:16-24. | ||||
Wazaify M, FU. Afifi, M El-Khateeb, Ajlouni K (2011). Complementary and alternative medicine use among Jordanian patients with diabetes. Complementary Ther. Clin. Pract. 17:71-75. Crossref |
||||
World Health Organization (WHO). http://www.who.int/topics/traditional_medicine/en/. Accessed on March 16, 2014. | ||||
Xue WL, Li XS, Zhang J, Lliu YH, Wang ZL, Rui-Juan Zhang RJ (2007). Effect of Trigonella foenum-graecum (Fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozocin-induced diabetic rats. Asia Pac. J. Clin. Nutr. 16 (Suppl 1):422-426. Pubmed |
||||
Zhou L, Fu P, Huang XR, Liu F, Chung AC, Lai KN, Lan HY (2010). Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am. J. Phys. Renal Physiol. 298:F1006-17. Crossref |
||||
Ziyyat A, Legssyer A, Mekhfi H, Dassouli A, Serhrouchni M, Benjelloun W (1997). Phytotherapy of hypertension and diabetes in oriental Morocco. J. Ethnopharmacol. 58:45-54. Crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0